Moleculair geleide onderzoeken met specifieke behandelingsstrategieën bij patiënten met geavanceerde nieuw-moleculair gedefinieerde subtypes van colorectale kanker KU Leuven
Colorectal cancer (CRC) is increasingly being recognized as a heterogeneous disease with distinct molecular subtypes. These subtypes have different biological processes at the basis of their disease and consequently their prognosis and responses to therapy are also different.
We have previously developed molecular diagnostic assays using a single platform on routine FFPE tumour biopsies. These assays identify gene expression profiles ...